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Highlights  
 
 Depressed patients have increased cortisol levels in comparison to controls using 
specimens that measure aggregate cortisol levels over a period of fifteen days. 
 Increased cortisol levels may be only explained for those severe episodes with non-
reactive mood and more prominent melancholic symptoms.  
 Depressed patients with severe fatigue were characterised by decreased cortisol 
levels. 
 
Abstract 
Background:  
The extent to which cortisol levels are elevated in major depressive episodes (MDE), and 
hence could act as a biomarker of illness, remains unclear.  Although patient characteristics 
may explain some of this variation – for example elevated cortisol being more often found in 
patients with severe, psychotic or melancholic depression – problems with the methods used 
to measure cortisol may also have contributed to the inconsistent findings. Fingernails are a 
novel sample that can be used to assess aggregate cortisol concentrations over a 15-day 
period, and may provide a more accurate reflection of longer term cortisol level changes in 
MDE and help clarify this issue. This methodology has not yet been utilised in MDE.    
Methods: Cortisol levels reflecting a period of 15 days were measured using fingernails in a 
group of 26 subjects experiencing a major depressive episode (MDE) and in an age and 
gender matched group of 45 healthy controls. 
Results: Depressed subjects showed significantly higher mean cortisol levels measured in 
fingernails when compared with control subjects. Higher levels of cortisol were associated 
with higher depression severity scores, a diagnosis of non-reactive depression, and more 
prominent melancholic symptoms. Conversely, fatigue was negatively correlated with 
cortisol levels. 
Conclusion: There is elevated cortisol in MDE when assessed using an aggregate measure 
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over two weeks. Alterations in fingernail cortisol correlate with key clinical symptoms and 
subtypes of depression.  
 
Introduction 
Hypercortisolaemia is considered a candidate biomarker potentially able to support the 
diagnosis or sub-typing of the major depressive disorder at biological level (Pariante 2009). 
However, there is some inconsistency in this finding, especially when using short-term 
measurements of cortisol concentrations such as salivary cortisol. This may be, in part, 
explained by the large heterogeneity seen within depressive syndromes. Indeed, it has been 
shown that depressive episodes with psychotic or melancholic features (Carroll et al., 2007, 
2012; Schatzberg et al., 2002), largely account for the increased cortisol levels found in this 
disorder. Furthermore, this could be also due to the susceptibility of these parameters to the 
influence of state variables, such as the day of the week, time of day or presence of transient 
extraneous factors liable to alter levels such as stress (Kudielka & Wüst, 2010). Fingernails, 
an integumentary type of tissue that share several properties with hair (Herane-Vives et al., 
2017), have recently been used and validated for measuring longer-term concentrations of 
cortisol (Ben Khelil et al. 2011; Izawa et al. 2015). The advantages of this methodology are 
manifold: it is non-invasive, economical in that repeated sampling can be avoided, and 
enables the assessment of cumulative cortisol concentrations over an extended period of time. 
To date, only one study has used this specimen in the mental health field for this purpose 
(Warnock et al. 2010) and none in subjects with major depression. Based on the background 
mentioned above, we designed this study with the objective to (1) compare fingernail cortisol 
concentrations in depressed subjects and matched healthy controls and (2) assess whether 
differences in cortisol levels are influenced by clinical variables in subjects with major 
depression. We hypothesised that subjects with major depressive episodes would be 
characterised by higher fingernail cortisol levels than healthy controls. 
 
Methods 
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 Participants 
Participants were recruited as part of an ongoing collaboration between London (UK), 
Santiago (Chile) and Hong Kong. Depressed participants were recruited via public 
advertisements (Wise et al. 2016) and from local psychological therapy and secondary care 
services. Twenty-six depressed patients were recruited, twenty in London (UK), six in 
Santiago (Chile) and none in Hong Kong.  All psychometric tools were English or validated 
Spanish/Chinese versions. Patients met DSM-IV criteria for a major depressive episode 
(MDE) in the context of either a unipolar or bipolar disorder, diagnosed using the Mini-
International Neuropsychiatric Interview (MINI) (Sheehan et al. 1998) and reported no 
history of psychiatric illness in first degree relatives. Depression severity was assessed with 
the Hamilton Depression Rating Scale (HAMD-17, Hamilton 1967) with only those scoring 
at clinical severity (≥ 13) included (Cleare et al 2015). Rating of depressive symptoms across 
sites was evaluated on an independent set of patients and showed a high inter-rater reliability 
(Intraclass correlation coefficient=0.96, p=0.004). The Quick Inventory of Depressive 
Symptoms was used as a self-rated measure of depressive symptoms (Rush et al, 1993). The 
Young Mania Rating Scale (Young et al. 1978) was used to exclude current 
hypomania/mania, while historical self-reported hypomanic symptoms were assessed using 
the 33-item hypomania checklist (HCL-33) (Feng et al. 2016). Melancholic symptoms of 
depression were assessed using the Newcastle Depression Diagnostic scale (NDDS, Carney 
et al. 1965) and atypical depression with the Atypical Depression Diagnosis Scale (ADDS, 
Stewart et al 1993). This latter scale provides four categories: (1) ‘non-reactive depression’, 
(2) ‘simple reactive depression’, (3) ‘probable atypical depression’ and (4) ‘a definite atypical 
depression’. The presence of rumination and irritability symptoms was established by using 
the Rumination Scale (Treynor et al. 2003) and the Self-Assessment of Irritability Scale 
(Snaith et al. 1978). Anxious symptoms were assessed using the “Anxiety Factor” on the 17-
item HAMD-17 (Levitt et al. 1993). Environmental factors in the three months prior to study 
participation were assessed using the Hassles Scale (Kanner & Coyne 1981) and the Recent 
Life Changes Questionnaire (Miller & Rahe 1997), while early life trauma was assessed with 
the Childhood Trauma Questionnaire (CTQ; Bernstein et al. 1994). The presence of 
childhood trauma was recorded if a participant presented with a score greater than the 
threshold on any of the following subscales of the CTQ: emotional abuse (threshold >12), 
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physical abuse (threshold >9), sexual abuse (threshold >7), emotional neglect (threshold >14) 
and physical neglect (threshold >9). Patients were medication free for ≥2 weeks (≥4 weeks 
for fluoxetine) and were not receiving any psychological intervention at the time of the 
assessment. Healthy controls were free from current or past psychiatric diagnoses as assessed 
using the MINI, as were their first-degree relatives using patient history. Participants were 
excluded if they reported any illicit substance use in the previous three months or had any 
unstable medical condition. Healthy controls were free from current or past psychiatric 
diagnoses as assessed using the MINI, and reported no history of psychiatric illness in first 
degree relatives. Participants were excluded if they reported any illicit substance use in the 
previous three months or had any unstable medical condition. Controls (n=45) were recruited 
from public advertisements and from hospital and university staff across the three sites from 
UK (n=15), Chile (n=2) and Hong Kong (n=28). The over recruitment of controls from 
Hong-Kong was undertaken in order to increase the statistical power of the study.  Controls 
were selected in order to match as closely as possible in age and gender with the depressed 
group. The local ethics committee approved the research and written informed consent was 
obtained from each participant. All participants received modest compensation for taking part 
in the research. 
Fingernail specimens  
Participants were instructed to clip their fingernails 15 days prior to the study assessment day 
in order to standardise the number of days’ growth to be sampled (approximately 1.5 mm per 
nail). Subjects were provided with detailed instruction on how to cut their fingernails 
accurately at the desired length at the 15-day time point, store the samples correctly and post 
them in specific containers back to the investigators. Cortisol was subsequently extracted 
according to the method described by Warnock and others (2010), with minor modifications. 
 
Fingernails extraction 
Fingernail samples were washed two times with 3 ml isopropanol (LC/MS grade) in glass 
vials and dried overnight. Next, 20-50 mg of the washed clippings were ground (Retsch ball 
mill mixer; 30 Hz) and 10-25 mg of accurately weighed specimen was used for cortisol 
extraction (1.5 ml LC/MS methanol; 1 hour on rotary mixer). Finally, after centrifugation, 1.3 
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ml of the methanol supernatant was transferred to a separate tube and evaporated to dryness 
at 60-degree Celsius under nitrogen. The residue was redissolved in 1 ml of assay buffer and 
stored at -30 degree Celsius until Immunoassay (Mondelli et al. 2010). All fingernail samples 
were analysed in the Affective Disorders Laboratory at the Bethlem Royal Hospital, London 
UK.  
Statistical analysis  
Data were checked for normality using graphic methods, such as histograms, and the 
Kolmogorov-Smirnov statistical test; results indicated that the fingernail cortisol data were 
not normally distributed (Figure 1).  Therefore, we used a non-parametric test (Mann-
Whitney U test) to compare fingernail concentration between MDE participants and healthy 
controls and the Kruskal–Wallis test when cortisol values were compared in more than two 
groups. Demographic and clinical data were compared using parametric statistical tests (t 
tests) for continuous variables and Chi-squared for categorical variables. Finally, a regression 
model was created to estimate the regression coefficient (β) and 95% confidence intervals 
(CI) of the variance in cortisol levels in fingernails in relation to clinical and demographic 
continuous and categorical predictors in MDE participants. We used Generalised Linear 
Models (GLMs) with a gamma distribution and a log-link function to model the data so as to 
better take into account the right-skew in the hormone concentrations in the tissue. The GLM 
is a flexible generalization of ordinary linear regression that allows for response variables that 
have error distribution models other than a normal distribution (Nelder et al 1972). The level 
of significance was set at p≤0.05 (two-tailed). 
 
Results 
Detailed demographic and clinical variables of the sample are presented in Table 1. Twenty-
six subjects with a MDE including one patient with bipolar disorder type I and two with 
bipolar disorder type II took part in the research and were sex and age matched with 45 
healthy controls. Twenty depressed patients were recruited in London (UK), six in Santiago 
(Chile) and none in Hong Kong. None of the patients showed significant current hypomanic 
symptoms.  Eleven subjects met criteria for atypical depression (42%) whereas 15 were 
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considered non-atypical (59%), based on the ADDS scale. As predicted, patients differed 
from controls on a number of clinical parameters including symptoms of depression and 
anxiety, ruminative thinking style, and early life and current environmental factors. There 
was no difference in the length of fingernail samples, waist circumference, or Body Mass 
Index (BMI) between groups. 
 
Fingernail cortisol level in depressed subjects vs. healthy controls 
Depressed subjects had significantly higher fingernail cortisol concentrations (FCC) (mean 
[SD]=201.2 [277.3] pg/mg, median [interquartile range, IQR]=96.4 [60.2–396.8 pg/mg]) in 
comparison to controls subjects using the Mann-Whitney U-test (mean [SD]=101.5 [90.5], 
median [IQR]=76.9 [39.2–165.6 pg/mg]; p=0.03). However, when we ran a sensitivity 
analysis excluding the 3 patients with bipolar disorder the difference between MDE and 
controls decreased to a trend level (p=0.09). There was no significant difference in FCC 
between different sites. FCC values for UK depressed participants were: mean [SD]=176.4 
[235.9] pg/mg, median [IQR]=94.1 [70.1–154.8 pg/mg] and for Chilean depressed subjects 
were: mean [SD]=193.6 [268.3], median [IQR]=96.4 [77.5–160.8 pg/mg]; p=0.27 using the 
Mann-Whitney U-test. FCC values for control subjects were: UK: mean [SD]=142.6 [194.8] 
pg/mg, median [IQR]=88.8 [62.9–121.3 pg/mg], Chile: mean [SD]=100.0 [85.3], median 
[IQR]=84.6 [62.0–105.3 pg/mg]; and Hong-Kong: mean [SD]=101.5 [90.5], median 
[IQR]=76.9 [62.0–105.4 pg/mg]; p=0.29 using the Kruskal–Wallis -test. 
Regression analyses of fingernail cortisol levels with clinical variables 
The generalised linear model showed that higher levels of cortisol were associated with 
higher depression severity scores, a diagnosis of non-reactive depression, and more 
prominent melancholic symptoms (all p<0.05; Table 2). Conversely, lower levels of cortisol 
were associated with more severe fatigue (p<0.05; Table 2). No other clinical variables 
exerted a significant effect on cortisol levels in comparison to healthy participants (all p > 
0.05).    
Discussion 
In this study we set out to measure differences in cortisol levels in MDE by using a novel 
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technique utilising fingernails, representing aggregate cortisol concentrations averaged over a 
period of 15 days. We demonstrated that fingernail cortisol concentration is increased overall 
in MDE compared with healthy controls. The GLM also showed that higher levels of cortisol 
were associated with higher depression severity scores, features of non-atypical depression, 
and more prominent melancholic symptoms. Conversely, more severe fatigue was associated 
with decreased cortisol levels. 
Medium-term cortisol levels 
These results suggest that overall cortisol levels are elevated during an MDE when assessed 
cumulatively over a 15-day period. This provides additional evidence over and above 
findings of elevated shorter-term measures of cortisol such as blood, saliva and urine, and 
strengthens the position of elevated cortisol release as an important neurobiological correlate 
of depression (Pariante 2009). Further support for the elevation of cortisol over longer time 
frames comes from studies using hair specimens from depressed patients, which usually 
cover longer periods of around 3 months (Dettenborn et al. 2012; Herane Vives et al 2016, 
Wei et al. 2015, Pochigaeva, 2017).  
Clarification that raised cortisol is a persistent phenomenon, particularly in those with more 
severe forms of depression with typical features, suggests that some patients with depression 
manifest the same neurobiological disturbance as Cushing’s syndrome, but in a less severe 
form. Chronic hypercortisolism in Cushing syndrome has a variety of potentially deleterious 
effects, including obesity, hypertension, glucose intolerance, osteoporosis, impaired immune 
function, and poor wound healing (Pennacchietti 2015). However, the degree of 
hypercortisolism, when present in depression, is of a milder form compared to that Cushing’s 
syndrome. For example, one study found a median fingernail cortisol of 679 pg/mg in 
Cushing’s syndrome (Thomson et al. 2010), which is much higher than the median of 96.4 
pg/mg in the current study, notwithstanding that direct comparison is hampered by some 
differences in the techniques used. Nevertheless, several depressed individuals did have 
fingernail cortisol levels in the 200-1000 pg/mg range (see Fig 1) which are more similar to 
those seen in Cushing’s syndrome.  Overall, however, the level of cortisol measured in 
depressed subjects appears to fall within the range described as subclinical hypercortisolism 
(Dalmazi & Pasquali 2015). This condition has to date been generally been applied to 
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subjects with ‘adrenal incidentalomas’ and not from depression. Given the potential impact of 
chronically elevated cortisol levels as demonstrated in fingernails, depression ought perhaps 
to be included within the remit of subclinical hypercortisolism.  
The occurrence of depressive recurrences would be expected to lead to repeated, periodical 
high level of cortisol (Mueller & Leon 1999).  This could potentially contribute to factors 
such as poorly controlled blood pressure (Bednarek & Jankowski 2014), raised glucose levels 
(Gillmer et al. 1975) and other more complex cardiovascular or metabolic condition often 
coexisting in subjects with subclinical hypercortisolism (Dalmazi & Pasquali, 2015) and 
depression (Katon, 2003). Another possible correlate of elevated cortisol is that of persistent 
cognitive impairment, which is present in some depressed patients and has been found to 
affect most of the cognitive domains (Porter et al. 2003). If the impaired cognition in patients 
with histories of more severe depression is linked to hypercortisolism, this raises the 
possibility that drugs such as mifepristone, a specific glucocorticoid receptor blocker, may 
have a therapeutic benefit in this neurocognitive impairment (Young et al. 2004).  
Relation to depression sub-type 
We found that higher fingernail cortisol was associated with more severe depression, and 
with depressive episodes characterised by melancholic and non-reactive mood of depression.  
This supports previous research suggesting that Hypothalamic–Pituitary–Adrenal (HPA) axis 
hyperactivity is more prominent in melancholic (Carroll & Feinberg 1981) and psychotic 
(Schatzberg et al. 2002) sub-types of depression. Therefore, elevated cortisol levels may be a 
potentially relevant biomarker particularly for those particular forms of depression. 
On the other hand, we did not find that fingernail cortisol was specifically linked to sub-type 
of atypical depression as the degree of broadly defined by the ADDS atypical 
symptomatology. Atypical depression has elsewhere been described to have lowered rather 
than elevated cortisol levels (Gold & Chrousos 2002). These previous studies assessed only 
short-term cortisol levels (Lamers et al. 2013; Gold & Chrousos 1999), and it is possible that 
hypocortisolaemia is not a chronic phenomenon in atypical depression.   
However, we did find that one of the features typically associated with atypical depression, 
severe fatigue, was negatively correlated with cortisol levels. Our results, therefore, provide 
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new evidence that indicates that this somatic symptom is linked to lowered cortisol levels, not 
only in other disorders which have commonly been associated with low cortisol levels, such 
as Chronic Fatigue Syndrome (Cleare 2003), but also in affective disorders, such as MDE. It 
has been suggested that lowered cortisol may be an aetiological factor in CFS (Cleare 2004), 
given that low dose cortisol replacement can alleviate the experience of fatigue (Cleare et al 
1999), which raises similar possibilities in patients with fatigue within affective disorders 
(Cleare 2009).   
 
Methods for assessing longer-term cortisol levels 
Cortisol measurement from fingernails presents a number of advantages over hair extraction, 
the other novel specimen recently introduced for measuring chronic cortisol levels over 
longer periods.  Specific confounding factors such as cosmetic treatment and frequency of 
washing for hair samples have not been found in fingernails, rendering results less 
susceptible to these extraneous factors, and facilitation easier matching of subject 
characteristics in case-control studies. Frequently, male subjects cannot be included in 
research using hair specimens because they are more likely to have a hair length shorter than 
three centimetres, the standard measure that these studies use (Dettenborn et al. 2010). 
Moreover, there remains a lack of agreement as to the optimal way to analyse hair samples 
(Pragst & Balikova 2006). Whilst some studies have ground hair before extracting cortisol, 
others have only cut them in small pieces (Davenport et al. 2006). The procedure of hair 
sampling can also have an aesthetic effect, leading potential subjects to avoid providing hair 
samples (Izawa et al. 2015).  In a recent community study, we found that 42% of subjects 
were unable to give hair due to shortness or baldness, while another 29% refused to give hair 
for various reasons (Fischer et al, 2016). 
Limitations 
There are some methodological issues in this study worthy of discussion. First of all, a more 
complete description of cortisol changes in depression could have been achieved by including 
another specimen alongside fingernails.  This would have revealed any differences in cortisol 
levels in this group of patients assessed across different time periods. Nevertheless, we 
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believe that the results using fingernails stand on their own and are an already validated 
method for measuring stable cortisol levels. Thus, fingernails have been demonstrated to be 
unaffected by acute influences (Izawa et al. 2015), a key requirement in order to reflect stable 
cortisol concentrations. Moreover, the use of fingernail cortisol has been validated in one 
recent study (Izawa et al. 2015) that found a positive and significant association between 
fingernail and hair cortisol levels – the latter being itself a now well-validated specimen for 
quantifying stable cortisol concentrations (D’Anna-Hernandez et al. 2011; Sauvé et al. 2007; 
Dettenborn et al. 2010). Finally, the fact that fingernails share the same keratinized features 
as hair (Herane-Vives et al. 2017) provides a theoretical underpinning of the results of Izawa 
et al (2015) suggesting that both specimens are likely to be reliable measures of chronic 
cortisol concentrations. Nevertheless, we suggest that further larger studies comparing these 
two specimens may help reinforce these findings.  
We must also acknowledge that our recruitment of patients and controls was not evenly 
balanced between centres, introducing potential site heterogeneity and ethnic variation.  
Whilst there is no evidence to date that fingernail cortisol differs between Asian and 
European or Latin cohorts, and we found no difference in our groups by centre of 
recruitment, an examination of ethnic differences was not a primary goal of the study.  Thus, 
it will be important for future studies to explicitly test whether there are subtle effects of 
ethnicity on fingernail cortisol measures, and for future studies of fingernail cortisol in 
depression to try to recruit a more homogeneous sample than we have done in order to 
eliminate possible confounding effects of centre or ethnicity.  
It is not clear why two specimens that have been validated for measuring chronic cortisol 
levels provide different levels of cortisol concentration. Indeed, several studies have detected 
an increased cortisol concentration in fingernails in comparison to hair samples (Raul et al. 
2004; Ben Khelil et al. 2011), suggesting that any potential wash-out effect in fingernails has 
a smaller impact on cortisol concentrations than in hair. Nevertheless, the actual magnitude of 
the potential wash-out effect in cortisol fingernail levels has not yet been explicitly studied.  
Wash out effects do play a clear role in diminishing cortisol concentration above the 3rd to 4th 
cm of hair (Kirschbaum et al. 2009). However, the average period of time assessed using 
fingernails in this study was equivalent to 0.61 cm of hair. Although it seems unlikely that 
there will have been a large washout effect in such a time period, we cannot definitively 
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exclude this as it has not been studied for such short periods of time/short lengths of hair.  It 
is possible, therefore, that there is an additional early wash-out effect on the first millimetres 
of hair as soon as this specimen leaves the epidermis, after which cortisol concentrations then 
remains stable up to the three cm point, after which time other factors – such as UV radiation, 
shampoo or dye – exert an effect and decrease cortisol levels in hair.  
Another possible factor of relevance relates to the expression of hydroxysteroid (11-beta) 
dehydrogenase 2 (HSD-2), the enzyme that converts either cortisol to cortisone or cortisone 
to cortisol. In fact, while several studies have found that cortisone concentrations are similar 
in fingernails and hair (Raul et al. 2004; Ben Khelil et al. 2011), cortisol concentrations were 
shown to be higher in fingernails (Ben Khelil et al. 2011) than in hair (Raul et al. 2004). It is 
possible, therefore, that hair-associated tissues, such as sweat glands (Raul et al. 2004) 
express larger amounts of HSD-2 in comparison to nail-associated tissues (e.g. the nail 
cuticle) leading to a differential cortisol/cortisone ratio in those tissues.  
However, this may prove to be less problematic than might first appear. Hair follicles are 
closely associated with two glands – the sebaceous gland and the apocrine gland. In scalp, the 
hair follicle and the sebaceous gland are fused both anatomically and functionally into what 
is called a pilosebaceous unit. But while the ducts of apocrine and sebaceous glands empty 
into the follicle, the ducts of eccrine glands, which are located near the follicles, do not empty 
into these structures but instead directly onto the skin surface. It means that, regardless of the 
amount of cortisol that these glands may deliver, this should be removed if this specimen is 
pre-washed with methanol before measuring cortisol inside the shaft, which is the cortisol 
which represents the systemic values (Grass et al. 2015). 
Another concern would be if the other potential sources of cortisol in hair, such as apocrine 
and sebaceous glands, overexpressed 11-β-HSD-2 in scalp relative to other tissues. However, 
we are not aware of any evidence that this is the case. Thus, it does not seem likely that 
differences in cortisol metabolising enzymes account for the observed differences in the 
amount of cortisol detected between hair and nail specimens. However, it seems more likely 
that other variables, such as differences in those mechanisms used by cortisol to cross cell 
membranes, may provide an explanation.  
First of all, it is important to highlight that for nails, in contrast to hair, no glandular elements 
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are found in the cuticle or its surrounding tissues. Therefore, all cortisol accumulated in nails 
comes from the systemic circulation. In relation to this point, it has been shown that several 
lipophilic substances such as lead and arsenic among others, are deposited in nail after 
diffusing passively form blood (de Berker et al. 2007). Therefore, cortisol, being a lipophilic 
hormone, should not be an exception. This mechanism of transportation is observed when 
substances move across an area of higher concentration to lower concentration. This means 
that cortisol would diffuse more easily when its systemic value is high. These episodes can be 
clearly found in two circumstances: in generalised hypercortisolemic status, such as a 
primary Cushing’s syndrome or in some subtypes of depression, or during periods when 
momentary increases of cortisol occur, such as those seen during early mornings. Thus, the 
physiology and histology of nails suggest that this specimen, instead of simply averaging 
daily cortisol outputs, as hair does, averages peaks of cortisol, at least in healthy people. In 
other words, nails preferentially accumulate cortisol when its concentration is high to freely 
diffuse from the systemic circulation. If this is the case, then our results may indicate that 
depressed outpatients have an increased medium-term cortisol reactivity levels in comparison 
to healthy people. 
In this article, we referred to the period of time over which cortisol is accumulated by 
fingernails as “medium-term”. We use this term since it is clear that we need to differentiate 
measures of acute cortisol levels, such as blood and saliva, from measures of chronic or 
averaged cortisol levels, such as hair and fingernails. However, it is also clear that the time-
frame covered by hair and fingernails differs; hair cortisol most commonly uses 3 cm of hair 
to represent the previous three months and fingernails (e.g. Warnock et al. 2010) the previous 
15 days, as we used here.  We wanted to choose a term that best encompasses this difference, 
and thus suggest using “medium-term” and “long-term”. We do consider that future research 
studies into cortisol changes in depression should focus on using short-, medium- and long-
term specimens, and that these may indeed measure different but complementary aspects of 
the disorder. 
Some limitations in the use of fingernails include possible effects on cortisol levels induced 
by nail growth rate, which can vary with seasonal changes, sex, different finger digits, 
clipping frequency, nail filing, and nail-biting habits (Gupta et al. 2005), although common 
cosmetic products such as nail varnish use are unlikely to affect fingernail cortisol (Ben 
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Khelil et al. 2011). Barker and others (2007) suggested that the length of fingernails is very 
important in relation to the concentration of cortisol extracted over a specific period of time. 
However, there were no differences in the length of fingernails between cases and controls in 
our sample, which indicates that the period covered by the nail specimens in this study was 
comparable between cases and controls. 
Future, larger studies using fingernails could compare more directly the degree of 
hypercortisolemia that depressed subjects present in comparison to subjects with clearly 
established hypercortisolism, such as those with Cushing’s syndrome, and link this to the 
presence of adverse metabolic and other physical effects. Studies using fingernails could also 
investigate cortisol levels in other specific non-atypical subtypes of depression, such as those 
with DSM specifiers such as anxious-distress, melancholic or psychotic features. Future 
studies might also investigate whether chronic hypercortisolemia in fingernails is a specific 
finding of unipolar or bipolar depression; given the small number of MDE patients with 
longitudinal diagnoses of bipolar disorder in the current study we have been unable to do this. 
This analysis seems particularly important since the exclusion of the small number of patients 
with bipolar disorder decreased the difference in cortisol levels compared to controls from a 
significant to a trend level. Longitudinal studies may also be helpful in validating the pattern 
of cortisol secretion in relation to other features of depressive illness such as remission, 
relapse, chronicity and comorbidity. Prospective cohort studies in young people with 
depression could evaluate whether cortisol may play a causative role in the association 
between medical conditions, such as diabetes and heart disease, and depression. 
Conclusions 
The use of fingernails for measuring cortisol levels aggregated over 15 days showed that 
depressed outpatients as a whole have elevated medium-term cortisol levels in comparison to 
control subjects. The present results also suggest that patients with more severe depression, 
and with non-reactive and melancholic features, are particularly at risk of elevated cortisol, 
whereas levels may be relatively lower in patients with marked fatigue. The demonstration 
that cortisol levels may be elevated over a longer time frame than previous research suggests 
that some depressive episodes may be part of a group of conditions that have subclinical 
hypercortisolaemia. The potential role of these longer-term elevations of cortisol in medical 
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conditions that occur at higher rates in depressed subjects needs to be further investigated.  
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Figure caption 
Figure 1: Distribution of Fingernail cortisol concentration (FCC) in controls and MDE 
participants 
 
 
 
 
 
 
Data were significantly skewed (p<0.05) according to the Kolmogorov-Smirnov test. 
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Table 1: Demographic and clinical characteristics of the sample 
Demographic and Clinical 
Variables  
Healthy 
Controls 
Depressed 
Subjects 
P 
valuea       
N (F/M) 45 (24/21) 26 (19/7) 0.1 
Age (Years), Mean (SD) 39.0 (10.3) 38.1 (12.1) 0.73 
Number of previous episodes, Mean  (SD) 0 (0) 2.6 (3.81) <0.01 
Duration of current episode (weeks), Mean 
(SD) 
0 (0) 90.2 (133.5) 
<0.01 
Number of admissions, Mean (SD) 0 (0) 0.17 (0.54) <0.01 
HAMD-17, Mean (SD) 0.4 (0.8) 19.0 (4.4) <0.01 
Anxiety Factor, Mean (SD) 0 (0) 5.8 (3.1) <0.01 
QIDS, Mean (SD) 0.4 (0.9) 17.9 (3.6) <0.01 
YMRS, Mean (SD) 0 (0) 0 (0) 1 
HCL-33, Mean (SD) 12.5 (8.0) 17.7 (5.4) 0.01 
NDDS, Mean (SD) 0 (0) 3.3 (2.4) <0.01 
History of childhood Trauma (CTQ), N (%) 3 (17.7) 18 (69.2) <0.01 
SAI, Mean (SD) 6.6 (4.7) 26.3 (7.2) <0.01 
Ruminations scale, Mean (SD) 31.0 (12.2) 89.3 (77.4) <0.01 
Life events score (RLCQ), Mean (SD) 114.5 (227.6) 384.0 (321.5) <0.01 
History of severe life events (RLCQ) (last 3 
months), N (%) 
3 (17.7) 20 (76.9) <0.01 
Number of Hassles (last month), Mean (SD) 22.3 (26.3) 100.0 (95.9) <0.01 
Number of Severe Hassles (last month), N (%) 1 (5.9) 11 (42.3) 0.01 
Length of fingernails (mm), Mean  (SD) 1.6 (0.5) 2.0 (0.9) 0.09 
Waist circumference (cm), Mean (SD) 83.2 (12.0) 89.3 (16.0) 0.18 
BMI (Kg/m2), Mean (SD) 24.8 (3.7) 26.9 (6.0) 0.21 
 
 
a
: t-test for continuous variable, Chi-squared for categorical variables. HAMD-17: 17-item Hamilton 
Depression Rating Scale; QIDS: 16-ite, Quick Inventory of Depressive Symptoms; NDDS: Newcastle 
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Depression Diagnostic Scale; HCL-33: 33-item Hypomania Checklist; SAI: Self Assessment of Irritability 
Scale; CTQ: Childhood trauma questionnaire; RLCQ: Recent Life Change Questionnaire; YMRS: Young 
Mania Rating Scale; BMI: Body Mass Index. 
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Table 2: Generalised linear model analysis between illness variables and fingernail cortisol 
concentration in MDE participants 
 
 Variable   Crude   Adjusted  
   β P value CI β P value CI 
Illness onset (years)  -0.02 0.25 -0.05; 0.01 0.02 0.38 -0.05; 0.02 
Number past episodes  -0.10 0.37 -0.07; 0.02 -0.01 0.59 -0.05; 0.03 
Number past admissions -0.02 0.89 -1.49; 1.29 0.09 0.88 -1.02; 1.19 
Duration of the episode (weeks) <0.01 0.98 0.01; 0.01 <-0.01 0.73 <-0.01; <0.01 
Severity of depression 0.09 0.02* 0.01; 0.16 0.05 0.20 -0.03; 0.13 
Fatigue symptoms   -0.05 0.26 -0.14; 0.03 -0.04 *0.04 -0.09; <-0.01 
Anxiety symptoms   0.11 0.05 <-0.01; 0.22 0.06 0.32 -0.06; 0.18 
Melancholic symptoms  0.19 0.01* 0.03; 0.34 0.12 0.17 -0.05; 0.31 
Non-reactive depression∫ 0.90 0.01* 0.2; 1.6 0.88 0.02* 0.08; 1.67 
Simple reactive depression∫ -0.26 0.65 -1.42; 0.89 -0.23 0.75 -1.67; 1.21 
Probable atypical depression∫  -0.28 0.50 -1.11; 0.55 -0.25 0.57 -1.14; 0.63 
Definitive atypical depression∫  -0.15 0.76 -1.19; 0.87 -0.14 0.79 -1.22; 0.93 
Irritability symptoms  -0.05 0.10 -0.12; 0.01 -0.03 0.33 -0.10; 0.03 
Rumination symptoms  <-0.01 0.28 <-0.01; <0.01 <-0.01 0.64 <-0.01; <0.01 
Hypomanic symptoms <-0.03 0.65 -0.18; 0.11 <-0.01 0.92 -0.10; 0.09 
Childhood trauma  -0.45 0.44 -1.60; 0.70 -0.23 0.62 -1.17; 0.70 
Daily hassles  <-0.01 0.65 -0.02; 0.01 <-0.01 0.87 -0.01; 0.01 
Recent Life events   <-0.01 0.06 <-0.01; <0.01 <-0.01 0.23 <-0.01; <0.01 
The β was calculated using GLM with a gamma distribution and a log-link function. Fingernail cortisol 
analysis was adjusted for age and gender. * P value significant at 0.05 and CI does not cross zero. CI: 95% 
Confidence interval. ∫: subtypes of depression based on ADDS scale 
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